AMGN34:BVMF
Amgen
75,52 R$
0,00%
(0,00) 1K
2-okt, 16:56:00 (GMT-3) · BRL
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoAMGN34 tikeri uchun statistika yaratilmoqda...
Ochish
75,76 R$
Yuqori
75,82 R$
Past
75,32 R$
Bozor kapitali
217,90 mlrd
Oʻrtacha hajm
376,00
Hajmi
112,00
52 haftalik eng yuqori
83,06 R$
52 haftalik eng past
47,76 R$
Muomaladagi aksiyalar
540,63 mln
Xodimlar soni
32 ming
Ochish
75,76 R$
Yuqori
75,82 R$
Past
75,32 R$
Bozor kapitali
217,90 mlrd
Oʻrtacha hajm
376,00
Hajmi
112,00
52 haftalik eng yuqori
83,06 R$
52 haftalik eng past
47,76 R$
Muomaladagi aksiyalar
540,63 mln
Xodimlar soni
32 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
MarketBeat
·
17 soat oldin
Amgen (NASDAQ:AMGN) Stock Purchase Disclosed by Rep. David Taylor
MarketWatch
·
1 kun oldin
Amgen Inc. stock underperforms Friday when compared to competitors
TipRanks
·
1 kun oldin
Amgen’s Evolocumab Study Signals Quiet Efficiency Gains for Cholesterol Franchise
TradingKey
·
1 kun oldin
Amgen Inc Stock (AMGN) Closed Down by 3.38% on Oct 1: What Investors Need To Know
Profil
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
Amgen haqida
CEORobert A. Bradway
Xodimlar soni31,5 ming
Asos solingan1980
Bosh ofislarTauzand-Oks, Kaliforniya, Amerika Qo‘shma Shtatlari
Sektor-
Veb-saytamgen.com